Humana Crecimiento futuro

Future controles de criterios 3/6

Se prevé que los ingresos de Humana disminuyan a un ritmo anual de 1.1%, mientras que se prevé que sus beneficios anuales crezcan a un ritmo de 25.9% por año. Se espera que el BPA crezca en un 27.4% al año.

Información clave

29.2%

Tasa de crecimiento de los beneficios

27.4%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Healthcare	20.9%
Tasa de crecimiento de los ingresos	-1.3%
Rentabilidad financiera futura	n/a
Cobertura de analistas	Low
Última actualización	26 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

No hay actualizaciones

Recent updates

Previsiones de crecimiento de beneficios e ingresos

LSE:0RF7 - Estimaciones futuras de los analistas y datos financieros pasados (SEK Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2025	9,430	238	443	415	3
12/31/2024	10,397	217	356	292	1
3/31/2024	9,621	146	484	654	N/A
12/31/2023	9,649	176	451	621	N/A
9/30/2023	9,684	228	316	508	N/A
6/30/2023	9,659	250	414	606	N/A
3/31/2023	9,491	232	414	606	N/A
12/31/2022	9,203	210	441	633	N/A
9/30/2022	8,869	183	490	520	N/A
6/30/2022	8,530	203	465	582	N/A
3/31/2022	8,347	242	481	598	N/A
12/31/2021	8,186	276	572	689	N/A
9/30/2021	8,000	293	593	813	N/A
6/30/2021	7,896	279	670	803	N/A
3/31/2021	7,825	272	603	736	N/A
12/31/2020	7,771	262	528	661	N/A
9/30/2020	7,750	230	543	613	N/A
6/30/2020	7,739	249	595	703	N/A
3/31/2020	7,670	197	434	662	N/A
12/31/2019	7,446	188	403	631	N/A
9/30/2019	7,247	222	327	556	N/A
6/30/2019	7,005	196	173	416	N/A
3/31/2019	6,774	245	265	425	N/A
12/31/2018	6,714	246	158	332	N/A
9/30/2018	6,600	228	252	396	N/A
6/30/2018	6,550	197	210	346	N/A
3/31/2018	6,541	199	90	216	N/A
12/31/2017	6,542	194	N/A	241	N/A
9/30/2017	6,635	195	N/A	-185	N/A
6/30/2017	6,684	241	N/A	-153	N/A
3/31/2017	6,540	226	N/A	-143	N/A
12/31/2016	6,362	148	N/A	-161	N/A
9/30/2016	6,140	139	N/A	255	N/A
6/30/2016	5,868	-11	N/A	202	N/A
3/31/2016	5,713	-53	N/A	233	N/A
12/31/2015	5,593	28	N/A	274	N/A
12/31/2014	5,065	38	N/A	156	N/A
12/31/2013	3,489	111	N/A	196	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (18.2% al año) de 0RF7 es superior a la tasa de ahorro (1.6%).

Beneficios vs. Mercado: Se prevé que los beneficios (18.2% al año) de 0RF7 crezcan más rápidamente que el mercado UK (12.2% al año).

Beneficios de alto crecimiento: Se espera que los beneficios de 0RF7 crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos de 0RF7 disminuyan en los próximos 3 años (-1.1% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos de 0RF7 disminuyan en los próximos 3 años (-1.1% al año).

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de 0RF7 se prevé que sea elevada dentro de 3 años.

Descubre empresas en crecimiento

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Humana Crecimiento futuro

Future controles de criterios 3/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

First quarter 2024 earnings released: EPS: kr0.44 (vs kr1.07 in 1Q 2023)

Full year 2023 earnings released: EPS: kr3.68 (vs kr4.38 in FY 2022)

New minor risk - Earnings quality

Humana AB (Publ) Announces Nomination Committee for the Annual General Meeting 2024

Humana Announces Board Changes, Effective May 1, 2024

Full year 2023 earnings released: EPS: kr3.68 (vs kr4.38 in FY 2022)

Humana Announces the Resignation of Johanna Rastad as President

Humana AB (publ) to Report Fiscal Year 2023 Results on Apr 03, 2024

New major risk - Revenue and earnings growth

Third quarter 2023 earnings released: EPS: kr1.72 (vs kr2.18 in 3Q 2022)

Humana AB (publ), Annual General Meeting, May 07, 2024

Humana AB (publ) to Report Q4, 2023 Results on Feb 08, 2024

Second quarter 2023 earnings released: EPS: kr0.75 (vs kr0.38 in 2Q 2022)

Investor sentiment improves as stock rises 19%

Investor sentiment improves as stock rises 43%

Humana AB (publ) Announces Board Appointments

Full year 2022 earnings released: EPS: kr4.38 (vs kr5.67 in FY 2021)

Investor sentiment improves as stock rises 18%

Full year 2022 earnings released: EPS: kr4.37 (vs kr5.67 in FY 2021)

Sören Mellstig Not Stands for the Re-Election to the Board of Humana AB (Publ)

Humana AB (publ) to Report Fiscal Year 2022 Results on Apr 03, 2023

Investor sentiment deteriorates as stock falls 51%

Humana AB (publ) to Report Nine Months, 2023 Results on Nov 09, 2023

Humana AB (Publ) Announces Management Changes

Third quarter 2022 earnings released: EPS: kr2.18 (vs kr2.54 in 3Q 2021)

Third quarter 2022 earnings released: EPS: kr2.18 (vs kr2.54 in 3Q 2021)

Humana AB (publ) to Report Q1, 2023 Results on May 04, 2023

Sön Mellllstig, Chairman of the Board of Humana Ab, Is Not Available for Re-Election at the 2023 Annual General Meeting

Humana AB Announces Nomination Committee for 2023 AGM

Second quarter 2022 earnings released: EPS: kr0.38 (vs kr1.19 in 2Q 2021)

Independent Chairman of the Board recently bought kr38m worth of stock

Noora Jayasekara Leaves Humana Member of Group Management

Humana AB (publ) (OM:HUM) acquired Vintergatan AB.

Humana AB (publ) (OM:HUM) completed the acquistion of Assistans For Dig I Sverige Ab.

Humana AB (publ) (OM:HUM) agreed to acquire Assistans For Dig I Sverige Ab for approximately SEK151 million.

First quarter 2022 earnings released: EPS: kr0.60 (vs kr1.28 in 1Q 2021)

Full year 2021 earnings released

Humana AB (publ) to Report Q3, 2022 Results on Nov 10, 2022

President & CEO recently bought kr180k worth of stock

President & CEO recently bought kr200k worth of stock

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Now 23% undervalued after recent price drop

Investor sentiment deteriorated over the past week

Humana AB (publ) (OM:HUM) acquired Kalliola Oy - Uudet Setlementtiratkaisut.

Third quarter 2021 earnings released: EPS kr2.54 (vs kr2.05 in 3Q 2020)

Director of Marketing & Communication Helena Pharmanson has left the company

Director of Human Resources Anna Skablova has left the company

Second quarter 2021 earnings released: EPS kr1.18 (vs kr0.94 in 2Q 2020)

Independent Director has left the company

Humana AB (Publ) Proposes No Dividend for the Financial Year 2020

First quarter 2021 earnings released: EPS kr1.28 (vs kr1.00 in 1Q 2020)

Full year 2020 earnings released: EPS kr4.94 (vs kr3.54 in FY 2019)

Full year 2020 earnings released: EPS kr4.94 (vs kr3.54 in FY 2019)

Revenue beats expectations

New 90-day high: kr65.45

Humana AB (publ) to Report Fiscal Year 2020 Results on Apr 01, 2021

Humana AB (publ) (OM:HUM) acquired J-son Företagspartner AB from Anna Maxe and David Jansson and family.

Humana AB (publ) Announces Nomination Committee for 2021 AGM

New 90-day high: kr61.80

New 90-day high: kr60.90

Third quarter 2020 earnings released: EPS kr2.05

Revenue misses expectations

Humana AB (publ) to Report Q3, 2021 Results on Nov 11, 2021

Humana AB (publ) to Report First Half, 2021 Results on Aug 20, 2021

Humana AB (publ) (OM:HUM) acquired RO Omsorg Assistans AB.

CEO & President recently bought kr249k worth of stock

Earnings released

New 90-day high - kr54.69

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

Descubre empresas en crecimiento